Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database.

Thomas HellandKari Britt HagenMartha Eimstad HaugstøylJan Terje KvaløySiri LundeKirsten LodeRagna Anne LindBirgitta Haga GripsrudKristin JonsdottirJennifer GjerdeErsilia BifulcoSteinar HustadJanne JonassenTurid AasTone Hoel LendeErnst Asbjørn LienEmiel Adrianus Maria JanssenHåvard SøilandGunnar Mellgren

Published in: Breast cancer research and treatment (2019)

This real-world data study suggests that measurements of tamoxifen metabolite concentrations may be predictive of vaginal dryness in breast cancer patients and verifies NorPD as a reliable source of adherence data.

Keyphrases

electronic health record
breast cancer cells
big data
positive breast cancer
ms ms
type diabetes
adverse drug
skeletal muscle
deep learning
glycemic control
weight loss